Today's special offer: Access for Free!!!

Bristol-Myers Squibb Co. (BMY) | Income Statement

See also

ˇ Show More

The income statement presents information on the financial results of a company's business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Bristol-Myers Squibb Co., Consolidated Income Statement

USD $ in millions

Export to Excel Export to OpenOffice.org
  12 months ended Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007
chart Net sales
chart Cost of products sold
chart Gross profit
chart Marketing, selling and administrative
chart Advertising and product promotion
chart Research and development
chart Acquired in-process research and development
chart Provision for restructuring
chart Litigation expense, net
chart Operating income
chart Equity in net income of affiliates
chart Gain on sale of ImClone shares
chart Interest expense
chart Interest income
chart Impairment and loss on sale of manufacturing operations
chart Gain on sale of product lines, businesses and assets
chart Other income received from alliance partners
chart Pension curtailment and settlement charges
chart Litigation (charges) recoveries
chart Product liability (charges) recoveries
chart Other
chart Other income (expense)
chart Earnings from continuing operations before income taxes
chart Provision for income taxes
chart Net earnings from continuing operations
chart Net earnings from discontinued operations
chart Net earnings
chart Net earnings attributable to noncontrolling interest
chart Net earnings attributable to Bristol-Myers Squibb Company
Source: Bristol-Myers Squibb Co., Annual Reports
Item Description The company
Net sales Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Bristol-Myers Squibb Co.'s net sales increased from 2009 to 2010 and from 2010 to 2011.
Operating income The net result for the period of deducting operating expenses from operating revenues. Bristol-Myers Squibb Co.'s operating income increased from 2009 to 2010 and from 2010 to 2011.
Earnings from continuing operations before income taxes Sum of operating profit and nonoperating income (expense) before income (loss) from equity method investments, income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Bristol-Myers Squibb Co.'s earnings from continuing operations before income taxes increased from 2009 to 2010 and from 2010 to 2011.
Net earnings from continuing operations This represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Bristol-Myers Squibb Co.'s net earnings from continuing operations increased from 2009 to 2010 and from 2010 to 2011.
Net earnings The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Bristol-Myers Squibb Co.'s net earnings declined from 2009 to 2010 but then slightly increased from 2010 to 2011.
Net earnings attributable to Bristol-Myers Squibb Company The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. Bristol-Myers Squibb Co.'s net earnings attributable to Bristol-Myers Squibb Company declined from 2009 to 2010 but then slightly increased from 2010 to 2011.

Top

Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center